Global Daridorexant Market Growth 2025-2031

The global Daridorexant market size is predicted to grow from US$ 128 million in 2025 to US$ 343 million in 2031; it is expected to grow at a CAGR of 17.8% from 2025 to 2031.

Daridorexant, sold under the brand name Quviviq, is a medication used to treat insomnia. It is an orexin receptor antagonist, specifically targeting both OX1 and OX2 receptors. This dual mechanism helps regulate sleep-wake cycles, making it effective for improving sleep onset and maintenance. Unlike benzodiazepines or Z-drugs, daridorexant does not interact with GABA receptors, offering a distinct way to manage sleep disorders.

The medication is taken orally and has a relatively short elimination half-life of around 8 hours, with a peak effect occurring within 1 to 2 hours after administration. Common side effects include headache, somnolence (sleepiness), and fatigue. Daridorexant was approved for use in the United States in January 2022 and became available in May 2022. It was also approved in the European Union in April 2022, marking the first orexin receptor antagonist to be available there. However, it is classified as a Schedule IV controlled substance in the United States, indicating a modest potential for misuse.

Daridorexant provides an alternative to traditional sleep medications, offering a distinct mechanism of action that may reduce the risk of dependence and tolerance associated with other sleep aids.

United States market for Daridorexant is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Daridorexant is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Daridorexant is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Daridorexant players cover Idorsia, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Daridorexant Industry Forecast” looks at past sales and reviews total world Daridorexant sales in 2024, providing a comprehensive analysis by region and market sector of projected Daridorexant sales for 2025 through 2031. With Daridorexant sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Daridorexant industry.

This Insight Report provides a comprehensive analysis of the global Daridorexant landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Daridorexant portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Daridorexant market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Daridorexant and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Daridorexant.

This report presents a comprehensive overview, market shares, and growth opportunities of Daridorexant market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
25mg
50 mg

Segmentation by Application:
Hospital and Clinic
Retail Pharmacies
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Idorsia

Key Questions Addressed in this Report

What is the 10-year outlook for the global Daridorexant market?

What factors are driving Daridorexant market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Daridorexant market opportunities vary by end market size?

How does Daridorexant break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.